UK cases are at their highest since 2014
Chikungunya is a mosquito-borne virus that causes fever and often severe, sometimes lasting, joint pain. UK Health Security Agency data shows travel-associated cases in England rose 43% in 2025, the highest total in over a decade, with most linked to travel to Sri Lanka, India and Bangladesh. If you are travelling to an area with ongoing transmission, our pharmacist can talk you through whether vaccination is right for your trip.
Chikungunya is a viral infection spread by the bite of an infected Aedes mosquito, the same mosquitoes responsible for dengue and Zika. Unlike many other mosquito species, Aedes mosquitoes are aggressive daytime biters and thrive in urban as well as rural settings.
Symptoms typically appear three to seven days after being bitten, and usually include a sudden high fever alongside severe joint pain, often in the hands, wrists, ankles and feet. Headache, muscle pain, rash and fatigue are also common. Most people recover within one to two weeks, but for a significant minority the joint pain persists for months, and occasionally longer. There is no specific antiviral treatment; care focuses on rest, fluids and pain relief.
Chikungunya is rarely fatal, though serious complications are more likely in older adults and people with underlying health conditions.
Transmission levels change through the year and by region, so it is always worth checking your specific destination before you travel. As a general picture for 2025 and 2026:
Sri Lanka, India and Bangladesh accounted for the majority of UK travel-associated cases in 2025, reflecting ongoing outbreaks in the region.
A marked rise in cases linked to returning travellers across Europe since late 2025.
Particularly Brazil, which has reported the largest case numbers globally through 2026.
Only limited local transmission in 2026, largely confined to a small number of cases in France.
We will check the current situation for your specific destination as part of your consultation, since outbreak patterns shift.
UKHSA's most recent annual data shows travel-associated chikungunya cases in England, Wales and Northern Ireland reached 160 in 2025, up 43% from 112 in 2024, the highest total recorded since 2014. Over half of all cases were reported in London. Most people affected had travelled to Sri Lanka, India or Bangladesh.
This reflects a genuine, measurable rise, not just increased awareness or testing. If you are travelling to an area with known transmission, it is worth discussing your risk with a travel health professional before you go.
We offer IXCHIQ®, one of the two chikungunya vaccines licensed in the UK. It is licensed for immunocompetent adults aged 18 to 59, so whether it is suitable for you depends mainly on your age and health — we confirm that with you at your consultation.
The chikungunya vaccine we provide. A live vaccine, licensed for immunocompetent adults aged 18 to 59. Following a UK safety review, IXCHIQ is restricted to this age range and should not be given to anyone aged 60 or over, anyone who is immunosuppressed, or anyone with a history of thymus disorder.
This restriction followed reports of very rare but serious reactions, predominantly in older adults, and reflects a confirmed UK regulatory position rather than a temporary pause.
The other chikungunya vaccine licensed in the UK — a newer, non-live vaccine for people aged 12 and over, with no current upper age limit. We do not stock it at present. If IXCHIQ is not suitable for you, call us and we will talk through your options rather than leave you without an answer.
Both are single-dose vaccines. We offer IXCHIQ®, which we order in for you rather than holding in stock — so please contact us before booking, particularly if you are travelling soon. Your pharmacist will confirm whether it is appropriate for you, and advise you if it is not.
Official UK guidance (JCVI) suggests vaccination may be worth considering in the following situations.
If you are a short-term holidaymaker heading to a low-transmission area, vaccination may be less relevant. Bite avoidance remains the first line of protection for everyone.
Our pharmacist will assess your specific itinerary and give you an honest recommendation, not a blanket one.
No vaccine is completely protective, and for many travellers bite avoidance is the main defence. Aedes mosquitoes bite mainly during the day and are common in urban areas, so precautions matter throughout the day, not just at dusk.
A DEET-based (or equivalent) insect repellent, reapplied regularly through the day.
Long sleeves and trousers, especially in areas with known transmission.
Accommodation with air conditioning or good screening, where that is an option.
Empty or cover standing water sources — Aedes mosquitoes breed in very small amounts of water.
Mild side effects, such as soreness at the injection site, tiredness or headache, are common for a day or two afterwards.
We would recommend booking a few weeks before travel where possible, to allow time for protection to develop, though we can advise on timing for shorter-notice trips too.
The chikungunya vaccination is £185 at Caxton Pharmacy. We confirm the full cost with you before anything goes ahead.
We would generally recommend a few weeks before departure to allow protection to develop, but contact us even if you are travelling soon — we will advise on what is realistic for your timeline.
No — we order it in for you rather than holding it on the shelf. Contact us as early as you can, particularly if you are travelling soon, and we will confirm how quickly we can get it in for you.
We offer IXCHIQ, which is restricted to adults 18 to 59 following a UK safety review, so we cannot give it to anyone aged 60 or over. Vimkunya, the other chikungunya vaccine licensed in the UK, has no upper age limit, but we do not stock it. Call us and we will advise on your options.
IXCHIQ, the vaccine we offer, is licensed for adults 18 to 59 only, so we are not able to vaccinate under-18s. Vimkunya is licensed from age 12 but we do not stock it. Call us and we will advise on the right approach for younger travellers.
Long-term protection data is still developing. We will advise on current guidance at the time of your appointment.
Usually yes — we will confirm this as part of your consultation based on what else you need.
Vaccination is a personal decision based on your specific itinerary, duration of stay and risk factors, not a blanket requirement. We will give you a clear, honest assessment rather than a generic recommendation.
Caxton Pharmacy, 3 Widmore Road, Bromley, Kent, BR1 1RL, serves patients across Bromley, Beckenham, Orpington, Chislehurst and West Wickham.
If you are travelling somewhere with known transmission, it is worth a conversation before you go. Our pharmacist will assess your specific risk and talk you through whether vaccination makes sense for your trip.